Long Acting Injectable Buprenorphine for Suboxone Tapering

Approach to Tapering:

1. Assess the Current Buprenorphine Dose:

  • ≤ 4 mg/day: Most patients experience no withdrawal or cravings.
  • Give 100 mg Sublocade once a month for 2 months → then stop.
  • 5–12 mg/day: Start with 300 mg once or twice, then 100 mg once or twice, then stop.
  • 16–24 mg/day: Use 300 mg for 2–3 months, then taper to 100 mg for 1–2 months, then stop.

2. Duration of Use:

  • Most patients need 2–4 shots total, depending on dose and response.
  • Some may need up to 5, especially if psychological dependence is strong.

    Why It Works:

    • The medication builds up in the system, offering a smooth taper with fewer cravings and withdrawals.
    • It eliminates the daily ritual of taking a pill, helping patients break the mental habit of needing a substance to feel normal.
    • Patients transition to a mindset of “I’m okay without taking anything”.

    About the Injections:

    • Sublocade: Long-standing option with a longer half-life.
    • Brixadi: Newer, with a shorter half-life but less painful, smaller volume, multiple injection sites, and no refrigeration required.
    • Both are highly effective; Brixadi is increasingly favored for its convenience.

    Final Thoughts:

    • These extended-release formulations have revolutionized how patients taper off Suboxone.
    • In clinical experience, over 100 patients have successfully come off buprenorphine using this approach.
    • Even for patients who initially struggle, restarting at a lower dose later often leads to success.
    https://www.spinejointnj.com/wp-content/uploads/2025/04/long-acting-buprenorphine-injection-.mp4
    author avatar
    Spine and Joint Pain Center